B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

GSK3A

MOLECULAR TARGET

glycogen synthase kinase 3 alpha

UniProt: P49840NCBI Gene: 293115 compounds

GSK3A (glycogen synthase kinase 3 alpha) is targeted by 15 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting GSK3A

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1alsterpaullone1.614
2indirubin1.393
3kenpaullone1.393
4myricetin-3-O-galactopyranoside [Supplementary Concept]1.102
5Apigenin 5,7,4'-trihydroxy-flavone,0.691
6chrysin0.691
7fisetin0.691
8Kaempferols0.691
9Luteolin 5,7,3',4'-tetrahydroxy-flavone,0.691
10Quercetin0.691
11Tannins Polyphenolic compounds with molecular weights of around 500-3000 daltons and containing enough hydroxyl groups (1-2 per 100 MW) for effective cross linking of other compounds (ASTRINGENTS).0.691
12Chlorhexidine0.691
13piceatannol0.691
14sp6001250.691
15Zearalenone (S-(E))-3,4,5,6,8,10-Hexahydro-14,16-dihydroxy-3-methyl-1H-2-benzoxacyclotetradec in-1,7(8H)-dione.0.691

About GSK3A as a Drug Target

GSK3A (glycogen synthase kinase 3 alpha) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 15 compounds with documented GSK3A interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

GSK3A inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.